| Primary |
| Product Used For Unknown Indication |
20.8% |
| Pneumonia |
20.6% |
| Drug Use For Unknown Indication |
10.4% |
| Sepsis |
6.3% |
| Infection |
5.2% |
| Peritonitis |
4.9% |
| Pneumonia Aspiration |
3.6% |
| Bacterial Infection |
3.4% |
| Pyrexia |
3.1% |
| Epilepsy |
2.6% |
| Lower Respiratory Tract Infection |
2.3% |
| Bipolar Disorder |
2.1% |
| Gastrointestinal Disorder Therapy |
2.1% |
| Hypertension |
2.1% |
| Klebsiella Infection |
2.1% |
| Lung Disorder |
2.1% |
| Pain |
1.8% |
| Acute Respiratory Distress Syndrome |
1.6% |
| Urinary Tract Infection |
1.6% |
| Abdominal Infection |
1.3% |
|
| Convulsion |
17.6% |
| Death |
9.2% |
| Pneumonia |
8.4% |
| Sepsis |
6.9% |
| Blood Bilirubin Increased |
6.1% |
| Renal Impairment |
5.3% |
| Interstitial Lung Disease |
4.6% |
| Septic Shock |
4.6% |
| Leukoencephalopathy |
3.8% |
| Off Label Use |
3.8% |
| Pyrexia |
3.8% |
| Vomiting |
3.8% |
| Agranulocytosis |
3.1% |
| Pancytopenia |
3.1% |
| Renal Failure |
3.1% |
| Thrombocytopenia |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Encephalopathy |
2.3% |
| Grand Mal Convulsion |
2.3% |
| Oxygen Saturation Decreased |
2.3% |
|
| Secondary |
| Pneumonia |
21.5% |
| Product Used For Unknown Indication |
21.1% |
| Peritonitis |
12.7% |
| Infection |
5.9% |
| Drug Use For Unknown Indication |
3.4% |
| Lung Abscess |
3.4% |
| Antibiotic Prophylaxis |
3.0% |
| Hypertension |
3.0% |
| Sedation |
3.0% |
| Sepsis |
3.0% |
| Analgesia |
2.5% |
| Dermatitis Infected |
2.5% |
| Pyrexia |
2.5% |
| Prophylaxis |
2.1% |
| Thrombosis Prophylaxis |
2.1% |
| Abdominal Infection |
1.7% |
| Agitation |
1.7% |
| C-reactive Protein Increased |
1.7% |
| Cardiac Failure Congestive |
1.7% |
| Catheter Related Complication |
1.7% |
|
| Renal Impairment |
14.5% |
| White Blood Cell Count Increased |
9.1% |
| Fungal Sepsis |
7.3% |
| Product Quality Issue |
7.3% |
| Pyrexia |
5.5% |
| Superinfection |
5.5% |
| Acute Coronary Syndrome |
3.6% |
| Blood Bilirubin Increased |
3.6% |
| Blood Creatinine Increased |
3.6% |
| Colonic Fistula |
3.6% |
| Convulsion |
3.6% |
| Hepatitis |
3.6% |
| Hyponatraemia |
3.6% |
| Leukopenia |
3.6% |
| Liver Disorder |
3.6% |
| Overdose |
3.6% |
| Oxygen Saturation Decreased |
3.6% |
| Platelet Count Decreased |
3.6% |
| Renal Failure |
3.6% |
| Shock |
3.6% |
|
| Concomitant |
| Hepatitis C |
19.7% |
| Product Used For Unknown Indication |
18.3% |
| Acute Lymphocytic Leukaemia |
11.3% |
| Drug Use For Unknown Indication |
8.5% |
| Anti-infective Therapy |
4.2% |
| Pneumonia Bacterial |
4.2% |
| Sedation |
4.2% |
| Anaesthesia |
2.8% |
| Bone Marrow Transplant |
2.8% |
| Constipation |
2.8% |
| Contraception |
2.8% |
| Infection |
2.8% |
| Lymphoma |
2.8% |
| Prophylaxis |
2.8% |
| Pulmonary Arterial Hypertension |
2.8% |
| Abdominal Abscess |
1.4% |
| Analgesic Intervention Supportive Therapy |
1.4% |
| Anticoagulant Therapy |
1.4% |
| Aortic Valve Replacement |
1.4% |
| Brain Abscess |
1.4% |
|
| Interstitial Lung Disease |
13.0% |
| Inappropriate Schedule Of Drug Administration |
8.7% |
| Blood Glucose Increased |
4.3% |
| Blood Pressure Decreased |
4.3% |
| Chills |
4.3% |
| Cholestasis |
4.3% |
| Constipation |
4.3% |
| Convulsion |
4.3% |
| Cough |
4.3% |
| Cyanosis |
4.3% |
| Device Related Infection |
4.3% |
| Haematocrit Increased |
4.3% |
| Hypertension |
4.3% |
| International Normalised Ratio Decreased |
4.3% |
| Liver Disorder |
4.3% |
| Myelodysplastic Syndrome |
4.3% |
| Nausea |
4.3% |
| Peripheral Coldness |
4.3% |
| Platelet Count Decreased |
4.3% |
| Pulmonary Embolism |
4.3% |
|
